Publications by authors named "Reham Ismail"

Rivaroxaban is a direct oral anticoagulant medication that has been found to be beneficial for the management of thromboembolic events linked to the Corona virus disease 2019 (COVID-19) pandemic, which has resulted in more than 6 million deaths worldwide. Hence, a sensitive, selective, and green bioanalytically validated method was developed using RP-HPLC coupled with DAD for the simultaneous determination of rivaroxaban in human plasma, and two co-administered drugs, namely, paracetamol, an analgesic, and ceftriaxone, an antibiotic, that are used in the management of COVID-19. An Exsil 100 ODS C18 column (250 × 4.

View Article and Find Full Text PDF

Background: Cut wounds and lacerations are common, but effective treatment is essential to achieve good cosmetic outcomes and maintain function. We assessed the use of local anaesthetic, infection control procedures, and antibiotics in the management of cut wounds and lacerations.

Methods: Eligible patients were those attending the emergency departments of Nasser and Dar Al Shifa Hospitals in the Gaza Strip with cut wounds or lacerations, from Aug 25 to Sept 2, 2018.

View Article and Find Full Text PDF

Purpose & Methods: Several single-nucleotide polymorphisms (SNPs) in the promoter region of the TNF-α gene can cause variations in the gene regulatory sites and act as risk factors for some autoimmune disorders as alopecia areata (AA) and vitiligo. This study aimed to detect the serum TNF-α (sTNF) level (by ELISA) and the rs1800629 (by real-time PCR) among AA and vitiligo Egyptian patients and to determine their relation with disease duration and severity. In silico analysis of this SNP to study the molecular regulation of the mutant genotypes was also done.

View Article and Find Full Text PDF